Location History:
- Madison, WI (US) (2011)
- Rio, WI (US) (2005 - 2019)
Company Filing History:
Years Active: 2005-2019
Title: Christopher W. Scherrer: Innovator in Solid Support Assay Systems
Introduction
Christopher W. Scherrer, based in Rio, Wisconsin, is an accomplished inventor with a notable portfolio of six patents. His work primarily focuses on advancements in solid support assay systems, a crucial area in biotechnological research and diagnostics.
Latest Patents
Among his latest contributions to the field are patents for solid support assay systems and methods utilizing non-standard bases. These patents describe innovative solid support assays where capture oligonucleotides, comprised of molecular recognition sequences, are attached to a solid support and hybridized with a target. Notably, these molecular recognition sequences may incorporate non-standard bases, enhancing hybridization with complementary tagging sequences of target oligonucleotides. Moreover, the incorporation of non-standard bases through mechanisms such as PCR or ligation plays a vital role in the assay processes detailed in Scherrer's patents.
Career Highlights
Christopher W. Scherrer has worked with prestigious companies like Eragen Biosciences, Inc. and Luminex Corporation. His experiences in these organizations have enriched his understanding and expertise in the domain of assay systems, allowing him to innovate and contribute effectively to the field.
Collaborations
Throughout his career, Scherrer has collaborated with professionals such as Jennifer K. Grenier and David J. Marshall. These partnerships have likely fostered a collaborative environment that enhances the development of innovative solutions in his field.
Conclusion
Christopher W. Scherrer's inventions in solid support assay systems utilizing non-standard bases represent significant advancements in biotechnology. His contributions not only reflect his expertise but also underscore the importance of collaboration in driving innovation forward. As an inventor, Scherrer's work continues to impact the industry and advance scientific research and diagnostics.